Rifampin for Injection USP, 600 mg*/vial (Sterile), supplied in sterile glass vials, Rx only For IV Infusion only, individually boxed, Mfd. for: Akorn, Inc., Lake Forest, IL --- NDC 17478-151-42
Published October 1, 2014 · Recall initiated: August 5, 2014
Summary
FDA records drug Class III recall D-1571-2014, published October 1, 2014 and initiated August 5, 2014. Recalling firm: Akorn, Inc.; Status: Terminated; Reported quantity: 5,539 vials; Lot: Lot: 12RIF4A, Expiration Date: 9/30/2014. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Impurity/Degradation Specification; high out of specification result for 23 transacetyl impurity at the 22 month stability time point
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Akorn, Inc.
- Distributor
- Nationwide
- Lot
- Lot: 12RIF4A, Expiration Date: 9/30/2014
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDALevofloxacin Ophthalmic Solution, 0.5%, 5 mL bottles, Rx Only, Manufactured by: Akorn, Inc., Lake Forest, ILJune 7, 2023
- FDALevofloxacin Injection 500mg/20 mL (25 mg/mL), For Intravenous Infusion, packaged in a) 20mL vials and b) 30June 7, 2023
- FDAClobetasol Propionate Cream, USP, 0.05%, packaged in a) 15g tubes, b) 30g tubes, and c) 60g tubes, Rx Only,June 7, 2023
- FDATropicamide Ophthalmic Solution, USP 0.1%, 15 mL bottles, Rx only, Distributed by: Akorn Operating CompanyJune 7, 2023
- FDABuprenorphine Hydrochloride Injection, CIII, 0.3 mg base/mL ,1 mL, 10 Carpuject Sterile Cartridge Units withOctober 1, 2014
- FDAPedi-Pak Pedi-Syringe Filter 35 mL Monoject Syringe Rx Only Genesis BPS, LLC The intended use is to prepareSeptember 24, 2014
Questions about this recall
Was Rifampin for Injection USP, 600 mg*/vial (Sterile), supplied in sterile glass vials, Rx only For IV Infusion only, individually boxed, Mfd. for: Akorn, Inc., Lake Forest, IL --- NDC 17478-151-42 recalled?
Yes. FDA published recall D-1571-2014 on October 1, 2014. Reported hazard: Failed Impurity/Degradation Specification; high out of specification result for 23 transacetyl impurity at the 22 month stability time point
What should I do if I have this product?
Voluntary: Firm initiated · Letter